Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric Basal-Bolus Therapy with Insulin Glargine vs Detemir
2009-012317-22Phase 4Completed
- Sponsor
- Azienda Ospedaliero-Universitaria delle Marche
- Start
- Jun 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin detemir and insulin glargine in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Azienda Ospedaliero-Universitaria delle Marche. Primary endpoint: Growth hormone and IGF-1 levels. Started Jun 2009; status: completed.
02
Drugs
insulin detemirinsulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2009-012317-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012317-22.